Fusion Antibody Share Price | |
---|---|
Price | 3.35 |
Bid | 3.30 |
Ask | 3.40 |
Change | -0.05 (-1.47%) |
Volume | 869,509 |
Open | 3.40 |
High | 3.40 |
Low | 3.35 |
Prev. Close | 3.40 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 95.37m |
Market Capitalisation | £3.19m |
Market Size | 10,000 |
52 Week High | 40.00 |
52 Week High Date | 11-May-2023 |
52 Week Low | 3.10 |
52 Week Low Date | 24-Nov-2023 |
# Trades | 26 |
---|---|
Vol. Sold | 350,019 |
Sold Value | £11.64k |
Vol. Bought | 269,490 |
Bought Value | £6.17k |
PE Ratio | -0.335 |
Earnings | -10.00 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
03-May-24 | 16:29:43 | 3.38 | 29 | Buy* | 3.30 | 3.40 | 0.98 | O Ordinary |
03-May-24 | 16:28:56 | 3.38 | 29 | Buy* | 3.30 | 3.40 | 0.98 | O Ordinary |
03-May-24 | 16:13:07 | 3.38 | 29 | Buy* | 3.30 | 3.40 | 0.98 | O Ordinary |
03-May-24 | 16:09:43 | 3.319 | 75,000 | Sell* | 3.30 | 3.40 | 2,489 | O Ordinary |
03-May-24 | 15:28:47 | 3.40 | 29 | Buy* | 3.30 | 3.40 | 0.99 | O Ordinary |
03-May-24 | 15:13:02 | 3.30 | 19 | Sell* | 3.30 | 3.40 | 0.63 | O Ordinary Trade was executed as an SI |
03-May-24 | 14:26:11 | 3.40 | 125,000 | Unknown* | 3.30 | 3.40 | 4,250 | O Ordinary Was reported as OTC |
03-May-24 | 14:26:09 | 3.395 | 125,000 | Unknown* | 3.30 | 3.40 | 4,244 | O Ordinary Was reported as OTC |
03-May-24 | 13:15:32 | 3.40 | 29 | Buy* | 3.30 | 3.40 | 0.99 | O Ordinary |
03-May-24 | 08:20:02 | 3.477 | 80,000 | Unknown* | 3.30 | 3.40 | 2,782 | O Ordinary Delayed publication |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
04-Dec-23 | 04-Dec-23 | Buy | Adrian Kinkaid held the position of CEO at the time of this trade.Adrian Kinkaid | 4.90 | GBX | 101,847 | 245,847 |
04-Dec-23 | 04-Dec-23 | Buy | Simon Gordon Douglas held the position of Chairman at the time of this trade.Simon Gordon Douglas | 4.96 | GBX | 100,565 | 356,365 |
12-Jun-23 | 09-Jun-23 | Buy | Richard John Buick held the position of Chief Scientific Officer at the time of this trade.Richard John Buick | 7.20 | GBX | 68,750 | 700,000 |
31-Oct-22 | 31-Oct-22 | Buy | Sonya Maria Ferguson held the position of Senior Independent Director at the time of this trade.Sonya Maria Ferguson | 41.91 | GBX | 10,000 | 102,567 |
20-Sep-22 | 20-Sep-22 | Buy | Adrian Kinkaid held the position of CEO at the time of this trade.Adrian Kinkaid | 53.90 | GBX | 4,000 | 4,000 |